39 results
S-3
TSNDF
TerrAscend Corp.
4 Apr 24
Shelf registration
4:43pm
revenues, expenses and anticipated cash needs, the medical benefits, viability, safety, efficacy, dosing and social acceptance of cannabis
8-K
EX-10.1
dlxkz92
7 Jul 23
Entry into a Material Definitive Agreement
11:11am
8-K
EX-10.2
zkvj6p8q91c i5qh
7 Jul 23
Entry into a Material Definitive Agreement
11:11am
8-K
EX-10.1
183ubqu7
5 Jul 23
TerrAscend Closes on Second Tranche of Private Placements for Total Aggregate Proceeds of US$20.5 Million
5:23pm
8-K
EX-10.2
u2drtdrfrnh70jyfwo
5 Jul 23
TerrAscend Closes on Second Tranche of Private Placements for Total Aggregate Proceeds of US$20.5 Million
5:23pm
8-K
EX-10.2
iak1de7xnq2ua1qk73k
29 Jun 23
TerrAscend Upsizes Previously Announced Offering to US $20 Million and Closes US $16 Million Initial Tranche
4:24pm
8-K
EX-10.1
x00 wp4d70kg3kl3rilr
29 Jun 23
TerrAscend Upsizes Previously Announced Offering to US $20 Million and Closes US $16 Million Initial Tranche
4:24pm